Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Further Information on US Private Placement

7th May 2014 07:00

RNS Number : 4072G
Devro PLC
07 May 2014
 



For immediate release 7 May 2014

 

 

Devro plc

("Devro")

 

Further Information on US Private Placement

 

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, today provides further details of the US private placement announced in the Interim Management Statement issued on 28 April 2014.

The private placement of senior unsecured notes was agreed on 17 April 2014 for a total of US$100 million, of which US$50 million was received in April 2014 and the remainder is expected to be received in June 2014. A significant proportion of this cash will be retained in US$ to fund the investment project in the USA, and the remainder will be swapped into sterling. The private placement notes provide funding with fixed terms of between 7 and 12 years, with an average fixed interest rate of 4.5%.

The raising of this debt ensures long term funding is in place to support the investment projects in the USA and China, and other cash needs. It also provides a more balanced funding structure between long and shorter term debt.

Devro offered the notes to certain institutional investors in a private placement exempt from the registration requirements of the U.S. Securities Act of 1933, as amended (the "Act"). The notes have not been and will not be registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Act.

 

ENDS

 

 

For further information, please contact:

 

Devro plc

Simon Webb, Group Finance Director

 

 

Tel No: 020 7182 4960

 

Buchanan

Charles Ryland / Sophie McNulty/

Clare Akhurst

 

 

 

Tel No: 020 7466 5000

 

Notes to Editors

 

FTSE listed Devro is one of the world's leading providers of collagen casings to the food industry supplying a wide range of products and technical support to manufacturers of sausages, salamis, hams and other cooked meats. The Group employs 2,200 staff across the world and produces its casings from five manufacturing sites based in Scotland, Australia, the Czech Republic and the USA. Devro reported sales of £242.7 million and profit before tax (before exceptional items) of £38.8 million for the year ended 31 December 2013. Devro is a constituent of the FTSE4Good Index Series which recognises that the company's performance meets globally recognised corporate responsibility standards.

 

Further information on Devro can be found on the company's website: www.devro.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAQKADPABKDDPK

Related Shares:

DVO.L
FTSE 100 Latest
Value8,415.25
Change7.81